Cancer Treatment Reviews
Volume 37, Issue 2 , Pages 133-142 , April 2011

Current and future adjuvant immunotherapies for melanoma: Blockade of cytotoxic T-lymphocyte antigen-4 as a novel approach

  • Sanjiv S. Agarwala

      Affiliations

    • Medical Oncology and Hematology, St. Luke’s Cancer Center, 801 Ostrum Street, Bethlehem, PA 18015, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 610 954 2145; fax: +1 610 954 2108.
    • ,
  • Steven J. O’Day

      Affiliations

    • The Angeles Clinical and Research Institute, 2001 Santa Monica Blvd, Suite 560W, Santa Monica, CA 90404, USA
    • Tel.: +1 310 582 7975; fax: +1 310 582 7979.

Received 31 March 2010 ,Accepted 14 June 2010.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0305-7372(10)00106-4

doi: 10.1016/j.ctrv.2010.06.001

Cancer Treatment Reviews
Volume 37, Issue 2 , Pages 133-142 , April 2011

Article Tools

* Image Usage & Resolution